Comments
Loading...
Ginkgo Bioworks Holdings Analyst Ratings and Price Targets | NYSE:DNA | Benzinga
Ginkgo Bioworks Holdings Inc has a consensus price target of $4.26 based on the ratings of 9 analysts. The high is $10 issued by TD Cowen on September 20, 2024. The low is $0.3 issued by Goldman Sachs on July 9, 2024. The 3 most-recent analyst ratings were released by TD Cowen, BTIG, and Goldman Sachs on September 20, 2024, August 23, 2024, and July 9, 2024, respectively. With an average price target of $5.77 between TD Cowen, BTIG, and Goldman Sachs, there's an implied -37.05% downside for Ginkgo Bioworks Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
BTIG
Goldman Sachs
Morgan Stanley
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Ginkgo Bioworks Holdings
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 09/20/2024 | Buy Now | 9.17% | TD Cowen | Brendan Smith36% | $3 → $10 | Maintains | Buy | Get Alert |
| 08/23/2024 | Buy Now | -23.58% | BTIG | Mark Massaro71% | $0.2 → $7 | Maintains | Sell | Get Alert |
| 07/09/2024 | Buy Now | -96.72% | Goldman Sachs | Matthew Sykes65% | $0.8 → $0.3 | Maintains | Sell | Get Alert |
| 06/26/2024 | Buy Now | -97.82% | BTIG | Mark Massaro71% | $0.5 → $0.2 | Maintains | Sell | Get Alert |
| 05/15/2024 | Buy Now | — | BTIG | Mark Massaro71% | — | Downgrade | Neutral → Sell | Get Alert |
| 05/15/2024 | Buy Now | -89.08% | Morgan Stanley | Tejas Savant51% | $2 → $1 | Maintains | Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | — | William Blair | Matt Larew25% | — | Downgrade | Market Perform → Underperform | Get Alert |
| 03/01/2024 | Buy Now | -67.25% | TD Cowen | Steven Mah51% | $7 → $3 | Maintains | Outperform | Get Alert |
| 01/23/2024 | Buy Now | -87.99% | Goldman Sachs | Matthew Sykes65% | $1.25 → $1.1 | Maintains | Sell | Get Alert |
| 01/22/2024 | Buy Now | -87.99% | Goldman Sachs | Matthew Sykes65% | $1.25 → $1.1 | Maintains | Sell | Get Alert |
| 11/15/2023 | Buy Now | -72.71% | Raymond James | Rahul Sarugaser20% | → $2.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/14/2023 | Buy Now | -72.71% | Raymond James | Rahul Sarugaser20% | → $2.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/09/2023 | Buy Now | — | BTIG | Mark Massaro71% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/05/2023 | Buy Now | -86.35% | Goldman Sachs | Matthew Sykes65% | $3 → $1.25 | Maintains | Sell | Get Alert |
| 06/02/2023 | Buy Now | -86.35% | Goldman Sachs | Matthew Sykes65% | $3 → $1.25 | Downgrade | Neutral → Sell | Get Alert |
| 05/11/2023 | Buy Now | — | William Blair | Matt Larew25% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/29/2022 | Buy Now | -34.5% | Berenberg | Gaurav Goparaju27% | → $6 | Initiates | → Buy | Get Alert |
| 10/04/2022 | Buy Now | -45.41% | Morgan Stanley | Tejas Savant51% | → $5 | Initiates | → Equal-Weight | Get Alert |
| 08/16/2022 | Buy Now | -34.5% | BTIG | Mark Massaro71% | $5 → $6 | Maintains | Buy | Get Alert |
| 08/16/2022 | Buy Now | 58.3% | Raymond James | Rahul Sarugaser20% | $11.5 → $14.5 | Maintains | Outperform | Get Alert |
| 06/16/2022 | Buy Now | -52.51% | Jefferies | Laurence Alexander75% | $11.5 → $4.35 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Ginkgo Bioworks Holdings (DNA) stock?
The latest price target for Ginkgo Bioworks Holdings (NYSE:DNA) was reported by TD Cowen on September 20, 2024. The analyst firm set a price target for $10.00 expecting DNA to rise to within 12 months (a possible 9.17% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ginkgo Bioworks Holdings (DNA)?
The latest analyst rating for Ginkgo Bioworks Holdings (NYSE:DNA) was provided by TD Cowen, and Ginkgo Bioworks Holdings maintained their buy rating.
When was the last upgrade for Ginkgo Bioworks Holdings (DNA)?
There is no last upgrade for Ginkgo Bioworks Holdings
When was the last downgrade for Ginkgo Bioworks Holdings (DNA)?
The last downgrade for Ginkgo Bioworks Holdings Inc happened on May 15, 2024 when BTIG changed their price target from N/A to N/A for Ginkgo Bioworks Holdings Inc.
When is the next analyst rating going to be posted or updated for Ginkgo Bioworks Holdings (DNA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ginkgo Bioworks Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ginkgo Bioworks Holdings was filed on September 20, 2024 so you should expect the next rating to be made available sometime around September 20, 2025.
Is the Analyst Rating Ginkgo Bioworks Holdings (DNA) correct?
While ratings are subjective and will change, the latest Ginkgo Bioworks Holdings (DNA) rating was a maintained with a price target of $3.00 to $10.00. The current price Ginkgo Bioworks Holdings (DNA) is trading at is $9.16, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
